New insights into NAFLD based on preclinical MRI studies

被引:1
|
作者
Bamburowicz-Klimkowska, Magdalena [1 ]
Ruzycka-Ayoush, Monika [1 ]
Cieszanowski, Andrzej [2 ,3 ,4 ]
Szeszkowski, Wojciech [4 ]
Bialek, Malgorzata [5 ]
Malkowska, Anna [1 ]
Grudzinski, Ireneusz P. [1 ]
机构
[1] Med Univ Warsaw, Dept Appl Toxicol, Banacha 1, PL-02097 Warsaw, Poland
[2] Maria Sklodowska Curie Mem Canc Ctr, Dept Radiol 1, Roentgena 5, PL-02781 Warsaw, Poland
[3] Inst Oncol, Roentgena 5, PL-02781 Warsaw, Poland
[4] Med Univ Warsaw, Dept Clin Radiol, Banacha 1a, PL-02097 Warsaw, Poland
[5] Polish Acad Sci, Kielanowski Inst Anim Physiol & Nutr, Inst 3, PL-05110 Jablonna, Poland
关键词
Fatty liver; Whole-body fat distribution; Magnetic resonance imaging; Rats; FATTY LIVER-DISEASE; ADIPOSE-TISSUE; OBESITY; EPIDEMIC; VOLUME;
D O I
10.1016/j.chemphyslip.2022.105192
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ABSTR A C T Background: Non-alcoholic fatty liver disease (NAFLD) is considered to be the leading cause of liver pathologies worldwide. Accurate diagnosis and staging of NAFLD is of utmost prognostic importance. Herein, we propose the application of multiparametric MRI in whole-body fat imaging that may serve in obesity and NAFLD diagnosis as we established based on an experimental preclinical model of high-calorie diet-induced NAFLD rats.Methods and results: Sprague Dawley male rats randomly divided into control and high-fat diet (HFD) groups to develop NAFLD were used in the experiments. After 12 weeks of the feeding the animals were subjected to MRI modalities based on the Dixon mode and DWI following T2-weighted imaging. Moreover, serum TAG, liver histopathological examination and liver fatty acids analysis (GC-MS) were also performed.The qualitative analysis of DWI images revelated the decrease of signals in the liver of rats subjected to HFD. The statistical analysis of signals from the water-and fat-separated voxels on Dixon images also showed the increase of the fat tissue along with the decrease of water molecules in the liver parenchyma of obese animals. The quantitative analysis of Dixon images allowed to estimate the statistically significant changes of whole-body fat profiles in both normal and obese rats. Histological analysis of the liver tissues, serum TAG and fatty acids profile in the livers confirmed the changes in the fat profile as demonstrated in MRI studies.Conclusions: The MRI-based modalities such as DWI and Dixon method provide both qualitative and quantitative data on the whole-body fat distribution and adipose tissues in the liver parenchyma of obese rats. The results show that MRI is a promising and reliable method and has potential to be used as a non-invasive translational biomarker in NAFLD.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Editorial: Will MRI-PDFF become the new standard for steatosis assessment in NAFLD?
    Pappa, Angeliki
    Wenzl, Tobias
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (03) : 364 - 365
  • [32] Light on Alzheimer's disease: from basic insights to preclinical studies
    Mi, Jie
    Liu, Chao
    Chen, Honglei
    Qian, Yan
    Zhu, Jingyi
    Zhang, Yachao
    Liang, Yizhi
    Wang, Lidai
    Ta, Dean
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [33] Metformin and retinal diseases in preclinical and clinical studies: Insights and review of literature
    Amin, Shivam, V
    Khanna, Saira
    Parvar, Seyedeh P.
    Shaw, Lincoln T.
    Dao, David
    Hariprasad, Seenu M.
    Skondra, Dimitra
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 247 (04) : 317 - 329
  • [34] Adipogenesis and therapeutic potentials of antiobesogenic phytochemicals: Insights from preclinical studies
    Murugan, Dharmani Devi
    Balan, Dharvind
    Wong, Pooi-Fong
    PHYTOTHERAPY RESEARCH, 2021, 35 (11) : 5936 - 5960
  • [35] Insights into recent preclinical studies on labelled cyclodextrin-based imaging probes: Towards a novel oncological era
    Kepes, Zita
    Hajdu, Istvan
    Fenyvesi, Ferenc
    Trencsenyi, Gyorgy
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 640
  • [36] MRI versus biopsy to assess NAFLD
    Claire Greenhill
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 (7) : 366 - 366
  • [37] MRI-based biomarkers of preclinical AD An Alzheimer signature
    Resnick, Susan M.
    Scheltens, Philip
    NEUROLOGY, 2012, 78 (02) : 80 - 81
  • [38] Genetic Insights for Drug Development in NAFLD
    Eslam, Mohammed
    George, Jacob
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2019, 40 (07) : 506 - 516
  • [39] The Emerging Role of Altered D-Aspartate Metabolism in Schizophrenia: New Insights From Preclinical Models and Human Studies
    Errico, Francesco
    Nuzzo, Tommaso
    Carella, Massimo
    Bertolino, Alessandro
    Usiello, Alessandro
    FRONTIERS IN PSYCHIATRY, 2018, 9
  • [40] Bone metastasis imaging with SPECT/CT/MRI: A preclinical toolbox for therapy studies
    Sanches, Pedro Gomes
    Peters, Steffie
    Rossin, Raffaella
    Kaijzel, Eric L.
    Que, Ivo
    Lowik, Clemens W. G. M.
    Grull, Holger
    BONE, 2015, 75 : 62 - 71